Senores Pharmaceuticals Q2 Results
- BSE: 544319
- NSE: SENORES
- ISIN: INE0RB801010
- Sector: Biotechnology & Drugs
BSE
840.60
15.65 (1.90%)
15.65 (1.90%)Volume2.88 K
Updated: Mon 9 Feb, 2026 | 11:51:45
NSE
838.2512.95 (1.57%)
12.95 (1.57%)Volume1.03 L
Updated: Mon 9 Feb, 2026 | 11:38:32
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Senores Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 120.34 | 109.82 | 9.58% | 81.27 | 48.07% |
| Depreciation/ Amortization | 8.09 | 5.99 | 35.06% | 3.89 | 107.97% |
| Operating Income | 41.42 | 28.17 | 47.04% | 19.36 | 113.95% |
| Net Income | 32.39 | 19.73 | 64.17% | 12.84 | 152.26% |
| Other Operating Expenses Total | 25.54 | 20.82 | 22.67% | 14.76 | 73.04% |
| Net Income Before Taxes | 40.64 | 26.49 | 53.42% | 15.95 | 154.80% |
| Total Revenue | 161.76 | 137.99 | 17.23% | 100.63 | 60.75% |
| Selling/ General/ Admin Expenses Total | 29.63 | 21.65 | 36.86% | 14.70 | 101.56% |
| Diluted Normalized EPS | 6.54 | 4.60 | 42.17% | 3.92 | 66.84% |